2.600USD+0.78%Mkt Cap: 831.85M $P/E: 4.10Today
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sc…
Industry Peers
Asset Management$188.30BUSDP/E 27.7
$173.43BUSDP/E 32.5
$102.02BUSDP/E 35.3
$78.91BUSDP/E 47.6
$51.04BUSDP/E 16.4
$48.36BUSDP/E 13.2
$47.20BUSDP/E 65.9
$37.63BUSDP/E 34.3
$35.82BUSDP/E 5.2
$34.23BUSDP/E 15.5
$33.39BUSDP/E 15.7
$32.35BUSDP/E 79.4
$28.75BUSDP/E 98.1
$23.94BUSDP/E 11.3
$23.90BUSDP/E 15.9
$21.52BUSDP/E 3.6
$21.39BUSDP/E 3.6
$21.06BUSDP/E 14.8
$20.63BUSDP/E 14.3
$20.03BUSDP/E 26.0
| Headline | Source | Time |
|---|---|---|
This week | ||
Older | ||
RTW Biotech Opportunities Ltd (LSE:RTW) Full Year 2025 Earnings Call Highlights: A Year of ... RTW Biotech Opportunities Ltd (LSE:RTW) reports a 36% NAV per share growth, outperforming major biotech indices and marking a significant year in public and private investments. | ||